Camtek (NASDAQ:CAMT) Releases Earnings Results, Meets Estimates

Camtek (NASDAQ:CAMT) issued its earnings results on Wednesday. The semiconductor company reported $0.99 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.99, FiscalAI reports. The business had revenue of $161.29 million during the quarter, compared to analyst estimates of $160.36 million. Camtek had a return on equity of 21.58% and a net margin of 7.40%. Camtek’s revenue for the quarter was up 28.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.82 earnings per share.

Here are the key takeaways from Camtek’s conference call:

• Camtek reported record third-quarter revenue of $161.3 million, up 28% year over year, and record operating income of $47.5 million. It forecast fourth-quarter revenue of about $180 million, 2026 revenue of about $595 million, and initial 2027 revenue above $800 million.
• Order momentum remains strong, with more than $800 million in orders received since the start of 2026 as of the company’s October investor event, and customers securing delivery slots into 2027. About 80% of orders were for advanced packaging, largely AI-related, while OSATs contributed slightly more than half.
• Third-quarter gross margin was 51.1%, slightly below expectations, as higher component and material costs and currency movements pressured costs. Camtek said supply constraints are also creating operational challenges, though it expects to meet delivery schedules and anticipates gradual margin improvement starting in 2027.
• Camtek expects service revenue to grow 35%–40% annually and plans to launch AI-based software products in 2027, with double-digit software revenue anticipated that year. It is targeting $1.2 billion in annual revenue within about three years, primarily through organic growth, with operating margins of 34%–36%.

Camtek Trading Down 9.4%

CAMT stock traded down $10.60 on Wednesday, reaching $101.77. The company’s stock had a trading volume of 572,422 shares, compared to its average volume of 500,508. The business has a fifty day simple moving average of $139.64 and a two-hundred day simple moving average of $156.77. Camtek has a 12-month low of $91.91 and a 12-month high of $215.99. The firm has a market cap of $4.75 billion, a PE ratio of 159.33, a PEG ratio of 2.16 and a beta of 1.69. The company has a debt-to-equity ratio of 0.69, a quick ratio of 6.58 and a current ratio of 7.38.

Analysts Set New Price Targets

Several research firms have issued reports on CAMT. Needham & Company LLC cut their price target on shares of Camtek from $190.00 to $170.00 and set a “buy” rating for the company in a research report on Friday, October 16th. Morgan Stanley lowered Camtek from an “equal weight” rating to an “underweight” rating and lowered their target price for the company from $152.00 to $126.00 in a research note on Monday. Stifel Nicolaus set a $170.00 target price on Camtek in a report on Monday, August 10th. B. Riley Financial decreased their price target on Camtek from $200.00 to $166.00 and set a “buy” rating on the stock in a research note on Tuesday, October 20th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Camtek in a research note on Tuesday, August 11th. Seven equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $172.17.

Key Stories Impacting Camtek

Here are the key news stories impacting Camtek this week:

• Positive Sentiment: Camtek reported record Q3 revenue of $161.3 million, up 28% year over year and slightly above analyst estimates. EPS was $0.99, matching one consensus estimate and narrowly beating another. Camtek Q3 results
• Positive Sentiment: Management expects approximately $180 million in Q4 revenue and gave an initial 2027 outlook for revenue above $800 million, signaling continued growth. Camtek Q3 results and outlook
• Negative Sentiment: Morgan Stanley downgraded Camtek to Underweight from Equalweight, with a $126 price target. The firm reportedly sees optimism as largely reflected in the valuation and cited risks around 2D inspection and pricing pressure, weighing on the outlook despite the company’s position in 3D chip metrology. Morgan Stanley’s Camtek assessment

Insider Buying and Selling at Camtek

In other news, Director Lior Aviram sold 3,347 shares of Camtek stock in a transaction dated Tuesday, August 11th. The shares were sold at an average price of $162.99, for a total transaction of $545,527.53. Following the sale, the director owned 15,865 shares of the company’s stock, valued at approximately $2,585,836.35. The trade was a 17.42% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Rafi Amit sold 6,250 shares of the business’s stock in a transaction dated Thursday, August 13th. The shares were sold at an average price of $170.52, for a total transaction of $1,065,750.00. Following the transaction, the chief executive officer owned 55,350 shares in the company, valued at $9,438,282. This represents a 10.15% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders sold 26,843 shares of company stock worth $4,514,249. 79.40% of the stock is owned by corporate insiders.

Camtek Company Profile

Camtek Ltd. (NASDAQ: CAMT) is an Israel-based provider of inspection and metrology equipment for the semiconductor industry. The company develops and manufactures systems that help chipmakers detect defects, measure manufacturing processes, and improve production yields during the fabrication and packaging of semiconductor devices.

Its product portfolio includes automated optical inspection and metrology systems for wafers, substrates, and packaged devices, along with inspection solutions for advanced packaging, memory, image sensors, and other specialty semiconductor applications.